DEF: The Oncology Institute Sets Date for 2025 Annual Stockholders Meeting, Proposes Reverse Stock Split

The Oncology Institute announces its annual stockholders meeting on May 7, 2025, featuring proposals including the election of directors, ratification of the accounting firm, and a potential reverse stock split.

Summary

• The Oncology Institute, Inc. will hold its annual meeting of stockholders virtually on May 7, 2025.
• Stockholders will vote on three proposals: electing eight directors, ratifying the appointment of BDO USA, P.C. as the independent accounting firm, and approving an amendment to the company's certificate of incorporation to allow for a reverse stock split.
• The board recommends voting 'FOR' all director nominees and both proposals.
• The proposed reverse stock split would be in a range of 1-for-5 to 1-for-40, at the discretion of the Board of Directors, to meet Nasdaq's minimum bid price requirement.
• The record date for determining stockholders eligible to vote is March 17, 2025.
• The company has engaged Morrow Sodali LLC as its solicitation agent for a fee of $12,500, plus telephone solicitation fees and reimbursement of expenses.
• The company is taking advantage of SEC rules allowing companies to furnish proxy materials over the Internet.
• The company qualifies as an emerging growth company and has elected to take advantage of certain exemptions from various reporting requirements.
• The Board of Directors met 18 times during the year ended December 31, 2024.
• The company has established an Audit Committee, a Compensation Committee, a Nominating and Corporate Governance Committee and a Compliance Committee.
• The company has adopted a written code of business conduct and ethics that applies to its directors, officers and employees.
• The company has adopted a Policy For Recovery Of Erroneously Awarded Compensation (the Clawback Policy), effective as of October 17, 2023.
• The company has adopted an Insider Trading Compliance Policy governing the purchase, sale and/or other dispositions of our securities by directors, officers, employees and other covered persons.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the company is addressing a negative situation (potential delisting), it is taking proactive steps to resolve it. The proxy statement itself is a standard corporate document.

Positives

• The company is taking steps to regain compliance with Nasdaq listing requirements through a proposed reverse stock split.
• The company has a comprehensive corporate governance structure with independent committees and a code of ethics.
• The company has implemented a clawback policy for erroneously awarded compensation.
• The company has an insider trading compliance policy to prevent illegal trading activities.

Negatives

• The company received a notification from Nasdaq indicating that the Company was no longer in compliance with Nasdaq Listing Rule 5550(a)(2), because the minimum bid price of the Company's Common Stock had closed below the Minimum Bid Price Requirement.
• The company may need to implement a reverse stock split, which can sometimes be viewed negatively by investors.

Risks

• Failure to regain compliance with Nasdaq's minimum bid price requirement could result in delisting of the company's stock.
• The reverse stock split may not increase the price of the common stock over the long term.
• The reverse stock split may decrease the liquidity of the common stock.
• The reverse stock split may result in some stockholders owning odd lots that may be more difficult to sell or require greater transaction costs per share to sell.
• The reverse stock split may lead to a decrease in our overall market capitalization.

Future Outlook

The company intends to regain compliance with Nasdaq's minimum bid price requirement and may effect a reverse stock split to achieve this.

Management Comments

• DANIEL VIRNICH CHIEF EXECUTIVE OFFICER: You are cordially invited to attend this years annual meeting of stockholders of The Oncology Institute, Inc. on May 7, 2025, at 11:00 A.M. Pacific Time.
• DANIEL VIRNICH CHIEF EXECUTIVE OFFICER: Your vote is important. Please vote as soon as possible by one of the methods shown above.

Industry Context

This announcement is typical for publicly traded companies, outlining the agenda for the annual meeting and addressing compliance with listing requirements. The reverse stock split proposal is a common strategy for companies facing delisting due to low stock prices.

Comparison to Industry Standards

• The Oncology Institute's corporate governance structure, with independent committees and a code of ethics, aligns with industry best practices.
• The engagement of Morrow Sodali LLC as a solicitation agent is a standard practice for public companies holding annual meetings.
• The proposed reverse stock split is a common strategy employed by companies facing delisting from exchanges due to low share prices; examples include companies like Ocugen Inc. and Cyren Ltd. who have recently undertaken similar actions.
• The fee paid to Morrow Sodali LLC is within the typical range for proxy solicitation services, which can vary based on the complexity of the proposals and the size of the shareholder base.

Stakeholder Impact

• Shareholders: The reverse stock split could impact the value and liquidity of their shares.
• Employees: The company's financial stability and future prospects could be affected by the outcome of the proposals.
• Customers: The company's ability to continue providing services could be impacted by its financial health.
• Creditors: The company's ability to meet its financial obligations could be affected by its financial performance.

Next Steps

• Stockholders to vote on the proposals outlined in the proxy statement.
• Board of Directors to determine whether to implement the reverse stock split and at what ratio, if approved by stockholders.
• Company to notify Nasdaq of its intention to effect the reverse stock split, if applicable.
• Company to provide public notice of the reverse stock split prior to the proposed market effective date, if applicable.

Key Dates

Keywords

reverse stock split, annual meeting, proxy statement, board of directors, corporate governance, Nasdaq, BDO USA, election of directors, compensation, audit committee, compliance, stockholders